Vice chair of the company’s executive committee, Joaquin Duato, will transition into the role of CEO and a board member, according to an Aug. 19 news release.
Mr. Gorsky was named chair and CEO of Johnson & Johnson in 2012. He led the company’s growth in orthopedic medical technology. In the second quarter of this year, Johnson & Johnson’s orthopedics sales hit $2.2 billion, jumping 53.4 percent year-over-year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
